Status:
TERMINATED
Effectiveness of Therapeutic Fasting and Specific Diet in Patients With Rheumatoid Arthritis
Lead Sponsor:
Charite University, Berlin, Germany
Collaborating Sponsors:
Braunschweig Integrated Centre of Systems Biology (BRICS), Germany
University of Luxembourg
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The aim of this trial is an evaluation of the effectiveness of fasting and a subsequent diagnosis-specific diet change in patients with rheumatoid arthritis in respect to improving rheumatic symptoms ...
Detailed Description
Rheumatoid arthritis is an inflammatory-destructive joint disease for which up to date etiopathogenetical causes are lacking. In recent years, numerous new therapeutic concepts have been developed in ...
Eligibility Criteria
Inclusion
- Rheumatoid arthritis
- free of any serious medical condition that precludes safe participation in an exercise program, such as coronary artery disease, severe hypertension, peripheral vascular disease, stroke, congestive heart failure, chronic obstructive pulmonary disease, insulin-dependent diabetes, psychiatric disease, renal disease, liver disease, active cancer other than skin cancer, and anemia
- Ability to understand the intervention concept and written consent to participate;
- Willingness to accept randomization and undergo the testing and intervention procedures and deliver stool, blood and urine samples for testing
- Age 18-70 years (inclusive)
- drug therapy was not started in the last 8 weeks before screening
Exclusion
- Gout or septic arthritis
- Psychiatric disease that interferes with the understanding and implementation of the intervention
- Pregnancy or breast feeding
- In the case of pronounced anemia (Hb \<10 mg / dl) no inclusion in the examination or no additional blood sampling is carried out
- Underweight (BMI \<18,5) or weight loss of \>3kg/5kg in the last/last 3 month(s)
- Eating disorder (such as bulimia, anorexia nervosa) in the last 5 years
- Current vegan nutrition
- Non-existence of email address or internet access
Key Trial Info
Start Date :
March 18 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 7 2021
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT03856190
Start Date
March 18 2019
End Date
July 7 2021
Last Update
February 7 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité Hochschulambulanz für Naturheilkunde, Immanuel Krankenhaus Berlin
Berlin, Germany, 14163
2
Charité University, Berlin, Department of Rheumatology and Clinical Immunology
Berlin, Germany